Trial Information
A Phase Ib, Open-Label, Multicenter Study Evaluating the Safety and Efficacy Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castrate Resistant Prostate Cancer
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724
